Stevioside | sweetener

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	57817-89-7
Formula :	C₃₈H₆₀O₁₈
M.W :	804.87
SMILES Code :	O=C([C@@]1(C)[C@@]2([H])CC[C@@](CC([C@]3(O[C@H]4[C@H](O[C@H]5[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O5)[C@@H](O)[C@H](O)[C@@H](CO)O4)CC6)=C)(C3)[C@]6([H])[C@]2(C)CCC1)O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7
MDL No. :	MFCD00079561

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

HepG2 cells	0, 12.5, 25, 50, 100 μM	24 hours	SS treatment augmented LC3B-II/LC3B-I levels and reduced SQSTM1 (p62) levels in a dose-dependent manner.	PMC9774531
Mouse chondrocytes	0, 10, 20, 40 μM	24 hours	STE significantly inhibited IL-1β-induced expression of iNOS and Cox-2, reduced the generation of MMP-13 and ADAMTS-4, and decreased the degradation of Aggrecan and Collagen II.	PMC9674883
Mouse chondrocytes	0, 10, 20, 40 μM	24 hours	To evaluate the effect of Stevioside on IL-1β-induced inflammatory response. Results showed that Stevioside significantly inhibited the expression of iNOS and COX-2, reduced the production of MMP-13 and ADAMTS-4, and protected the degradation of cartilage matrix components Aggrecan and Collagen II.	PMC9674883
3T3-L1 preadipocytes	100-200 μM	7 days	To investigate the effect of stevioside on lipid accumulation in 3T3-L1 adipocytes. Results showed that stevioside dose-dependently reduced intracellular lipid accumulation.	PMC8997985
Human hair follicle dermal papilla cells (HDPs)	0, 0.2, 1, 5, 10, 50 µM	24 and 48 hours	Stevioside alone did not significantly affect the proliferation of human hair follicle dermal papilla cells. At 48 h, stevioside showed 3-5% cytotoxicity in human HDP cells at 10 µM concentration.	PMC7766712
Human keratinocytes (HaCaT)	0, 0.2, 1, 5, 10, 50 µM	24 and 48 hours	Stevioside alone promoted the proliferation of human keratinocytes. Compared to the control (CTR), the proliferation of HaCaT cells was increased by 15% after 48 h of treatment with 10 µM stevioside.	PMC7766712

Db/db mice	Non-alcoholic fatty liver disease model	Oral	40 mg/kg/day	Once daily for 3 weeks	S and SS reduced the body and liver weight and levels of serum triglyceride, total cholesterol, and hepatic lipogenic proteins. In addition, S and SS increased the levels of fatty acid oxidase, peroxisome proliferator-activated receptor alpha (PPARα), and microtubule-associated protein light chain 3 B but decreased that of sequestosome 1 (p62) in the liver of db/db mice.	PMC9774531
Mice	Trpm5-lacZ+/− mice	Oral	0.5 mM		Enhanced Trpm5 activity, promoting IL-25 release and hyperplasia in tuft cells	PMC6431192
C57BL/6 male mice	OA model induced by destabilization of the medial meniscus (DMM)	Oral	50 mg/kg/day	Twice a day for 8 weeks	To evaluate the protective effect of Stevioside on DMM-induced osteoarthritis. Results showed that Stevioside significantly attenuated cartilage degeneration and reduced OARIS scores.	PMC9674883
Db/db mice	Obesity and diabetes model	Oral gavage	40 mg/kg/day	Once daily for 3 weeks	To investigate the effect of stevioside on epididymal adipose tissues in db/db mice. Results showed that stevioside reduced adipocyte size and improved glucose tolerance and insulin resistance.	PMC8997985

{[proInfo.proName]}

CAS No.: 57817-89-7

{[proInfo.proName]}

CAS No.: 57817-89-7

Alternative Products

Product Details of Stevioside

Safety of Stevioside

Related Pathways of Stevioside

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT02880124	Carbohydrate Ingestion ... More >> Fuel Selection Athletic Performance Less <<	Not Applicable	Recruiting	December 2017	Canada, Quebec ... More >> Centre d'éducation physique et sportive de l'Université de Montréal (CEPSUM) Recruiting Montréal, Quebec, Canada, H3C 3J7 Contact: Mélanie F Paradis, M.Sc. 514-571-4122 melanie.paradis@umontreal.ca Contact: Lorianne Lavoie, B.Sc. 514-466-3393 lorianne.lavoie@umontreal.ca Principal Investigator: Jonathan Tremblay, Ph.D. Less <<
NCT02634164	Hyperglycemia	Not Applicable	Completed	-	-
NCT03115385	Obesity, Abdominal ... More >> Adiposity Less <<	Not Applicable	Terminated(Funds ended.)	-	United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Less <<
NCT02411565	Ovarian Cancer	Not Applicable	Terminated(Drug manufacturing ... More >>issues) Less <<	-	United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02825823	Exercise Keto... More >>nes Dietary Supplements Less <<	Not Applicable	Completed	-	Canada, British Columbia ... More >> University of British Columbia, Okanagan. Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT02677649	Fecal Microbiota	Not Applicable	Completed	-	United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT03486145	High Blood Pressure ... More >> Flow Mediated Dilation Less <<	Not Applicable	Completed	-	United States, Arizona ... More >> Arizona State University Phoenix, Arizona, United States, 85004 Less <<
NCT03510624	Type 2 Diabetes Mellitus	Phase 1	Not yet recruiting	June 1, 2019	-
NCT03667703	Congenital Heart Disease ... More >> Upper Gastrointestinal Bleeding Stress Ulcer Infection Less <<	Not Applicable	Not yet recruiting	June 30, 2021	United States, Massachusetts ... More >> Boston Children's Hospital Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Kimberly I Mills, MD 617-355-7866 kimberly.mills@cardio.chboston.org Contact: Ben D Albert, MD 617-355-7866 ben.albert@childrens.harvard.edu Less <<
NCT03680482	Diabetes Mellitus, Type 2	Not Applicable	Completed	-	-
NCT03724864	Dental Caries	Not Applicable	Completed	-	Italy ... More >> Pediatric dentistry dept Sassari, Italy Less <<
NCT02580110	Healthy Subjects	Not Applicable	Completed	-	Sweden ... More >> Food for Health Science Centre, Medicon Village, Lund University Lund, Sweden, , SE-223 81 LUND Less <<
NCT01757990	Dental Caries	Phase 2	Completed	-	-
NCT02800707	Impaired Glucose Tolerance	Not Applicable	Completed	-	United States, Minnesota ... More >> ECRC Minneapolis, Minnesota, United States, 55454 Less <<
NCT03708939	Glucose Intolerance ... More >> Glucose, Low Blood Glucose, High Blood Less <<	Not Applicable	Enrolling by invitation	January 1, 2021	Israel ... More >> Weizmann Institute of Science Reẖovot, Israel Less <<
NCT02146183	Glycogen Depletion	Not Applicable	Unknown	July 2015	Denmark ... More >> Aarhus University Hospital, Dept of Clinical medicine Recruiting Aarhus C, Denmark, 8000 Contact: Per B Jeppesen, Prof, PhD +45-28151877 per.bendix.jeppesen@ki.au.dk Principal Investigator: Per B Jeppesen, Prof, PhD Sub-Investigator: Søren Larvsen, Prof-Sport Less <<
NCT01115088	Obesity Type ... More >>2 Diabetes Less <<	Not Applicable	Completed	-	United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02834715	Diabetes Mellitus	Not Applicable	Completed	-	Cameroon ... More >> National Obesity Centre Yaounde, Cameroon Less <<
NCT01488383	Hyperglycemia ... More >> Hypertension Less <<	Not Applicable	Withdrawn(not i)	September 2013	Spain ... More >> Basque Public Health Service-Osakidetza (Lakuabizkarra primary care center and Txagorritxu hospital) Vitoria-Gasteiz, Alava, Spain, 01009 Less <<
NCT03259685	Gut Microbiota ... More >> Metabolic Syndrome Less <<	Not Applicable	Recruiting	December 2020	Canada ... More >> Laval University Recruiting Québec, Canada, G1V0A6 Contact: Marie-Claude Vohl 418-656-2131 ext 4676 marie-claude.vohl@ulaval.ca Less <<
NCT05852145	pH\|Microbiome\|Dental Plaque	PHASE1\|PHASE2	NOT_YET_RECRUITING	2025-12-24	-

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	1.24mL 0.25mL 0.12mL	6.21mL 1.24mL 0.62mL	12.42mL 2.48mL 1.24mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed